| scholarly article | Q13442814 |
| P356 | DOI | 10.1121/1.429418 |
| P698 | PubMed publication ID | 10875392 |
| P50 | author | Paul L Carson | Q41278441 |
| Oliver D. Kripfgans | Q55113933 | ||
| P2093 | author name string | D L Miller | |
| J B Fowlkes | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 3480-3486 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Journal of the Acoustical Society of America | Q26182 |
| P1476 | title | Cavitation nucleation agents for nonthermal ultrasound therapy | |
| P478 | volume | 107 |
| Q30375867 | Blinking Phase-Change Nanocapsules Enable Background-Free Ultrasound Imaging. |
| Q45889026 | Combined shock-wave and immunogene therapy of mouse melanoma and renal carcinoma tumors |
| Q41066998 | Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents |
| Q30410631 | Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging |
| Q92471753 | Delivering Focused Ultrasound to Intervertebral Discs Using Time-Reversal |
| Q30455782 | Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons. |
| Q38612537 | Drug-Loaded Perfluorocarbon Nanodroplets for Ultrasound-Mediated Drug Delivery |
| Q73179467 | Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents |
| Q30451679 | Evolution of acoustically vaporized microdroplets in gas embolotherapy |
| Q26861530 | Improving the performance of phase-change perfluorocarbon droplets for medical ultrasonography: current progress, challenges, and prospects |
| Q44239730 | Lithotripter shock waves with cavitation nucleation agents produce tumor growth reduction and gene transfer in vivo |
| Q63547125 | Microbubbles, Nanodroplets and Gas-Stabilizing Solid Particles for Ultrasound-Mediated Extravasation of Unencapsulated Drugs: An Exposure Parameter Optimization Study |
| Q51735650 | Optimal dosage of ultrasound contrast agent for ultrasound surgery: thermal effect of linear plane wave. |
| Q38980428 | Optimizing Acoustic Activation of Phase Change Contrast Agents With the Activation Pressure Matching Method: A Review |
| Q33898006 | Phase change events of volatile liquid perfluorocarbon contrast agents produce unique acoustic signatures. |
| Q30450112 | Phase transitions of nanoemulsions using ultrasound: experimental observations |
| Q51164308 | Phase transitions of perfluorocarbon nanoemulsion induced with ultrasound: a mathematical model. |
| Q30373053 | Phase-change contrast agents for imaging and therapy. |
| Q30466278 | Phase-shift, stimuli-responsive drug carriers for targeted delivery |
| Q30450131 | Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer |
| Q27308582 | Phase-transition thresholds and vaporization phenomena for ultrasound phase-change nanoemulsions assessed via high-speed optical microscopy. |
| Q51093890 | Quantitative relations of acoustic inertial cavitation with sonoporation and cell viability. |
| Q50243074 | Spatial and temporal observation of phase-shift nano-emulsions assisted cavitation and ablation during focused ultrasound exposure |
| Q46859124 | Spatial control of gas bubbles and their effects on acoustic fields. |
| Q50250740 | Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo |
| Q93349306 | Vaporization Detection Imaging: A Technique for Imaging Low-Boiling-Point Phase-Change Contrast Agents with a High Depth of Penetration and Contrast-to-Tissue Ratio |
Search more.